Site of insulin resistance in type 1 diabetes: Insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro

Journal of Clinical Endocrinology and Metabolism

Volumn 59, Issue 6, 1984, Pages 1183-1192

  Yki Järvinen, Hannele ^a   Taskinen, Marja Riitta ^a   Kiviluoto, Tuula ^b   Hilden, Hannele ^a   Helve, Eero ^a   Koivisto, Veikko A ^a   Nikkiläa, Esko A ^a  

^a Helsinki University Hospital ^*  (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE C 14; INSULIN; INSULIN I 125; NEUTRAL INSULIN; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; CLINICAL ARTICLE; DRUG RECEPTOR BINDING; DRUG RESISTANCE; DRUG THERAPY; ENDOCRINE SYSTEM; GLUCOSE OXIDATION; GLUCOSE TRANSPORT SYSTEM; HUMAN; HUMAN CELL; INSULIN BINDING; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOGENESIS; PHARMACOKINETICS; PRIORITY JOURNAL; SOFT TISSUE; THERAPY;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; RECEPTOR, INSULIN;

EID: 0021743282     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-59-6-1183     Document Type: Article

References (34)

1. DeFronzo RA, Hendler R, Simonson D 1982 Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 31:795
2. Yki-Järvinen H, Koivisto V 1984 Continuous subcutanous insulin infusion therapy decreases insulin resistance in type 1 diabetes. J Clin Endocrinol Metab 58:659
3. Del Prato S, Nosadini R, Tiengo A, Tessari P, Avogaro A, Trevisan R, Valero A, Muggeo M, Cobelli C, Toffolo G 1983 Insulin-mediated glucose disposal in type 1 diabetes:evidence for insulin resistance. J Clin Endocrinol Metab 57:904
4. Lager I, Lönnroth P, von Schenck H, Smith U 1983 Reversal of insulin resistance in type 1 diabetes after treatment with continuous subcutaneous insulin infusion. Br Med J 287:1661
5. Martin FIR, Stocks AE 1967 Insulin sensitivity and 131-1 metabolism in juvenile-type diabetes. Aust Ann Med 16:289
6. Waldhäusl WK, Bratusch-Marrain P, Kruse V, Jensen I, Nowotny P 1983 Impaired insulin sensitivity in IDDM is not only linked to elevated insulin binding capacity. Diabetes [Suppl 1] 32:4A
7. Berson SA, Yalow RS 1959 Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest 38:1996
8. Oakley WG, Jones VE, Cunliffe AC 1967 Insulin resistance. Br Med J 2:134
9. Pedersen 0 1983 Insulin receptor assays used in human studies: merits and limitations. Diabetes Care 6:301
10. WHO Expert committee on Diabetes Mellitus 1980 Second report. WHO Tech Rep Ser No 646
11. DeFronzo RA, Tobin JD, Andres R 1979 Glucose clamp techniques method for quantifying insulin secretion and resistance. Am J Physiol 237:E214
12. Yki-Järvinen H, Koivisto V 1983 Effects of body composition on insulin sensitivity. Diabetes 32:965
13. McGuire EAH, Helderman JH, Tobin JD, Andres R, Berman M Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565
14. Arner P, Arner O, Ostman J 1973 The effect of local anaesthetic agents on lipolysis by human human adipose tissue. Life Sci 13:161
15. Pedersen O, Hjjillund E, Lindskov HO 1982 Insulin binding and action on fat cells from young healthy females and males. Am J Physiol 243:E158
16. Hirsch J, Gallian E 1968 Methods for the determinations of adipose cell size in man and animals. J Lipid Res 9:110
17. Pedersen O, Hjollund E, Beck-Nielsen H, Lindskov HO, Sonne O, Gliemann J 1981 Insulin receptor binding and receptor-mediated insulin degradation in human adipocytes. Diabetologia 20:636
18. Gliemann J, Sonne O 1978 Binding and receptor-mediated degradation of insulin in adipocytes. J Biol Chem 253:7857
19. Kashiwagi A, Verso MA, Andrews J, Vasquez B, Reaven G, Foley JE 1983 In uitro insulin resistance of human adipocytes isolated from subjects with non-insulin dependent diabetes mellitus. J Clin Invest 72:1246
20. Jorgensen KH, Larsen UD 1980 Homogenous mono 125-I-insulins. Preparation and characterization of mono 125-I(Tyr A14)-and mono-125(Tyr A19)-insulin. Diabetologia 19:546
21. Anyan Jr WR 1978 Adolescent Medicine in Primary Care. New York, Wiley and Sons, p 137
22. Desbuquois B, Aurbach GD 1971 Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33:732
23. Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26:22
24. Welch SG, Boucher BJ 1978 A rapid microscale method for measurement of hemoglobin A(1a+1b+1c). Diabetologia 14:209
25. Dixon WJ (ed) 1981 BMDP Statistical Software. University of California Press, Berkeley
26. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP 1981 The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30:1000
27. Pedersen O, Hjollund E 1982 Insulin receptor binding to fat and blood cells and insulin action in in fat cells from insulin-dependent diabetics. Diabetes 31:706
28. Olefsky JM 1976 Effects of fasting on insulin binding, glucose, transport, and glucose oxidation in isolated adipocytes. Relationships between insulin receptors and insulin action. J Clin Invest 58:1450
29. Foley JE, Kashiwagi A, Verso MA, Reaven G, Andrews J 1983 Improvement in in vitro insulin action after one month of insulin therapy in obese noninsulin-dependent diabetics. J Clin Invest 72:1901
30. Kolterman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM 1981 Receptor and postreceptor defects contribute to the insulin resistance in noninsulin dependent diabetes mellitus. J Clin Invest 68:957
31. Bjorntorp P, Berchtold P, Holm J, Larsson B 1971 The glucose uptake by human adipose tissue in obesity. Eur J Clin Invest 1:480
32. Heding LG 1972 Determination of total serum insulin in insulin treated patients. Diabetologia 8:260
33. Francis AJ, Home PD, Hanning I, Alberti KGMM 1983 Intermediate acting insulin given at bedtime.effect on blood glucose concentrations before and after breakfast. Br Med J 286:1173
34. Kolterman OG, Insel OG, Saekow M, Olefsky JM 1980 Mechanism of insulin resistance in human obesity. J Clin Invest 65:1272